FAM23B activators are chemical compounds that modulate the activity of the protein encoded by the FAM23B gene, a member of the broader family of genes known for their roles in various cellular processes. The "FAM" nomenclature typically stands for "family with sequence similarity," indicating a grouping based on shared genetic sequences. The biological functions of the FAM23B protein are not fully elucidated, but proteins in this family often have roles in cellular structure, signal transduction, or enzymatic activity. Activators of this particular protein influence its activity, which can have downstream effects on the cellular functions it controls. The exact mechanism by which FAM23B activators exert their effect can vary, but generally, these molecules interact with the protein to enhance or stabilize its active form, potentially influencing the protein's ability to interact with other molecules or perform its function within the cell.
The chemical structure of FAM23B activators can be diverse, encompassing various scaffolds and functional groups that are optimized to interact with the FAM23B protein. The design of these molecules is often informed by the three-dimensional structure of the protein, as well as the nature of the activators' binding site. High-throughput screening methods, computational modeling, and structure-activity relationship (SAR) studies are commonly employed in the identification and optimization of these activators. These techniques allow researchers to refine the chemical properties of FAM23B activators to enhance their potency and specificity. In the context of cellular biochemistry, the involvement of FAM23B activators can have significant impacts on protein-protein interactions and the regulation of pathways in which FAM23B is a participant. The precise conformational changes induced by the binding of these activators to FAM23B are critical for their function, with the goal of modulating the protein in a way that affects its inherent activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations, possibly affecting calcium-dependent signaling pathways that FAM23B might be involved in, thus indirectly enhancing its activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can modulate signaling pathways that influence FAM23B's function, leading to its indirect enhancement. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a kinase inhibitor that can alter signaling pathways by inhibiting enzymes that compete with or negatively regulate the pathways FAM23B may be involved in, thereby potentially enhancing its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor which can disrupt PI3K/Akt signaling. This alteration might enhance FAM23B's activity by shifting the balance of signaling pathways in cells. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P engages with sphingosine-1-phosphate receptors leading to activation of downstream signaling pathways that could intersect with the pathways involving FAM23B, potentially enhancing its activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis by inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), which could enhance FAM23B's activity through the modulation of calcium-dependent signaling pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that can increase intracellular calcium levels, thus indirectly enhancing FAM23B's activity by affecting calcium-related signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that could favor pathways associated with FAM23B by inhibiting competitive signaling routes, thereby indirectly enhancing its functional activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK inhibitor that can shift signaling dynamics to favor pathways in which FAM23B may function, potentially enhancing its activity by decreasing competing pathway signals. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor that might lead to the selective activation of pathways associated with FAM23B by inhibiting kinases that negatively regulate these pathways. | ||||||